Motion Acquisition (DCGO)
(Real Time Quote from BATS)
$3.48 USD
+0.09 (2.66%)
Updated May 2, 2024 03:10 PM ET
4-Sell of 5 4
B Value F Growth C Momentum D VGM
Income Statements
Fiscal Year end for DocGo Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 624 | 441 | 319 | 0 | NA |
Cost Of Goods | 429 | 286 | 209 | 0 | NA |
Gross Profit | 195 | 155 | 110 | 0 | NA |
Selling & Adminstrative & Depr. & Amort Expenses | 180 | 133 | 94 | 0 | 0 |
Income After Depreciation & Amortization | 15 | 22 | 15 | 0 | 0 |
Non-Operating Income | 0 | 0 | 5 | 0 | NA |
Interest Expense | -2 | -1 | 1 | 0 | NA |
Pretax Income | 16 | 23 | 20 | 0 | NA |
Income Taxes | 6 | -8 | 1 | 0 | NA |
Minority Interest | 3 | -4 | -5 | 0 | NA |
Investment Gains/Losses | 0 | 0 | 0 | 0 | NA |
Other Income/Charges | 0 | 0 | 0 | 0 | NA |
Income From Cont. Operations | 10 | 31 | 19 | 0 | NA |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | NA |
Net Income (GAAP) | 7 | 35 | 24 | 0 | NA |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 31 | 35 | 22 | 0 | 0 |
Depreciation & Amortization (Cash Flow) | 16 | 13 | 7 | 0 | NA |
Income After Depreciation & Amortization | 15 | 22 | 15 | 0 | 0 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 105.62 | 102.98 | 94.86 | NA | NA |
Diluted EPS Before Non-Recurring Items | 0.05 | 0.33 | 0.21 | NA | NA |
Diluted Net EPS (GAAP) | 0.06 | 0.34 | 0.25 | -0.06 | NA |
Fiscal Year end for DocGo Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 199.25 | 186.55 | 125.49 | 113.00 |
Cost Of Goods | NA | 132.56 | 131.50 | 83.62 | 81.23 |
Gross Profit | NA | 66.69 | 55.05 | 41.87 | 31.78 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 55.02 | 46.35 | 40.29 | 38.68 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 11.67 | 8.70 | 1.58 | -6.90 |
Non-Operating Income | NA | 0.52 | 0.10 | -1.11 | 0.04 |
Interest Expense | NA | -0.01 | -0.35 | -0.52 | -0.81 |
Pretax Income | NA | 12.20 | 9.16 | 0.99 | -6.05 |
Income Taxes | NA | 4.20 | 4.53 | -0.36 | -2.13 |
Minority Interest | NA | 0.42 | -0.13 | 3.35 | -0.45 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 7.99 | 4.63 | 1.34 | -3.92 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 7.57 | 4.76 | -2.01 | -3.47 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 103.50 | 104.99 | 103.59 | 102.58 |
Diluted EPS Before Non-Recurring Items | NA | 0.06 | 0.05 | -0.02 | -0.03 |
Diluted Net EPS (GAAP) | NA | 0.06 | 0.05 | -0.02 | -0.03 |